Imatinib-induced melasma-like pigmentation

Imatinib is a tyrosine kinase inhibitor anti-cancer drug. Different hypotheses include the formation of a drug-melanin metabolite, drug-induced cytotoxic response to epidermal “neo antigen” and the presence of a specific KIT mutation and its interaction with other receptors. [4] Declaration of patie...

Full description

Saved in:
Bibliographic Details
Published inIndian journal of dermatology Vol. 64; no. 2; pp. 158 - 159
Main Authors Subhadarshani, Sweta, Abhishek, G
Format Journal Article
LanguageEnglish
Published India Wolters Kluwer India Pvt. Ltd 01.03.2019
Medknow Publications and Media Pvt. Ltd
Medknow Publications & Media Pvt. Ltd
Wolters Kluwer - Medknow
Wolters Kluwer Medknow Publications
Subjects
Chemotherapy
Correspondence
Drug dosages
Inhibitor drugs
Patients
Side effects
Skin
Online AccessGet full text

Cover

More Information
Summary:Imatinib is a tyrosine kinase inhibitor anti-cancer drug. Different hypotheses include the formation of a drug-melanin metabolite, drug-induced cytotoxic response to epidermal “neo antigen” and the presence of a specific KIT mutation and its interaction with other receptors. [4] Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0019-5154
1998-3611
DOI:10.4103/ijd.IJD_302_17